TSPAN33 and autoimmune disease: When it comes to other members of the tetraspanin family, also TSPAN33 is highly expressed by activated B cells and in several B cell malignancies [91] and has been proposed to serve as a useful therapeutic target in diseases (B cell malignancies and autoimmune diseases) characterized by an activated phenotype of B cells [91,92].